@article{4e2cd5697c8e49b884c3ec007de1de56,
title = "No evidence of survival benefit with addition of gemtuzumab ozogamicin to standard medical research council induction chemotherapy",
keywords = "Aminoglycosides, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Leukemia, Myeloid, Acute, Male, Myelodysplastic Syndromes",
author = "Jensen, \{Morten Krogh\}",
year = "2013",
month = may,
day = "1",
doi = "10.1200/JCO.2012.47.9238",
language = "English",
volume = "31",
pages = "1700",
journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
issn = "0732-183X",
publisher = "Lippincott Williams and Wilkins",
number = "13",
}